NAV19/09/2024 Var.+22.3499 Type of yield Focus sugli investimenti Società d'investimento
3,098.3899USD +0.73% reinvestment Equity Worldwide Candriam 

Investment strategy

Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world. The fund seeks to achieve capital growth by investing in the principal assets traded and to outperform the benchmark while also generating a positive social impact over the long term, by selecting companies that address certain societal challenges and mobilise resources in the fight against cancer. The management team makes discretionary investment choices based on economic/financial analyses, but also on the basis of Candriam's internal analysis of environmental, social and governance (ESG) criteria.
 

Investment goal

Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world.
 

Dati master

Type of yield: reinvestment
Fondi Categoria: Equity
Region: Worldwide
Settore: Sector Health / Pharma
Benchmark: MSCI World (Net Return)
Business year start: 01/01
Ultima distribuzione: -
Banca depositaria: CACEIS Bank, Luxembourg Branch
Domicilio del fondo: Luxembourg
Permesso di distribuzione: Austria, Germany, Switzerland, Czech Republic
Gestore del fondo: Rudi Van Den Eynde, Linden Thomson
Volume del fondo: 1.89 bill.  USD
Data di lancio: 14/11/2018
Investment focus: -

Condizioni

Sovrapprezzo emissione: 0.00%
Tassa amministrativa massima: 0.80%
Investimento minimo: 0.00 USD
Deposit fees: -
Redemption charge: 0.00%
Prospetto semplificato: Download (Print version)
 

Società d'investimento

Funds company: Candriam
Indirizzo: 19-21 route d'Arlon, 8009, Strassen
Paese: Luxembourg
Internet: www.candriam.com
 

Attività

Stocks
 
96.09%
Cash
 
3.91%

Paesi

United States of America
 
53.00%
Switzerland
 
12.20%
Germany
 
7.97%
United Kingdom
 
6.70%
Denmark
 
6.31%
Japan
 
4.46%
Cash
 
3.91%
Ireland
 
1.90%
Cayman Islands
 
1.86%
Netherlands
 
1.32%
China
 
0.37%

Filiali

Pharma/Biotechnology
 
69.50%
Healthcare services
 
14.66%
Healthcare appliances
 
11.93%
Cash
 
3.91%